H.Res. 484 · 117th Congress
Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.
- Stage
- In committee
- Sponsor
- Mariannette Miller-Meeks
- Introduced
- 2021-06-17
- Latest action
- 2022-11-01 · Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Summary
This resolution expresses the sense of the House of Representatives that the United States should not waive intellectual property protections for COVID-19 vaccines, treatments, or other related innovations.